As depicted in Table S1, during the immune cell type analysis, we observed that CD4+ T cells and type‐2 DCs decreased, while CD8+ T cells and plasmacytes significantly increased in all three batches of recurrent bladder tumours, indicating an expected stronger immune response in recurrent tumours. The gene discussed is CD8A; the disease is neoplasm.